CongressBuys
Committee overlap: Finance

Sen. Ron Wyden sold Eli Lilly and Company (LLY)

Sen. Ron Wyden (D-OR) · $50K–$100K · traded Feb 10, 2025

Why this is a committee overlap

Wyden is the Ranking Member of the Senate Committee on Finance, which oversees Drug Manufacturers companies. Eli Lilly and Company is classified in the Drug Manufacturers - General industry.

An overlap is a fact about the trade, not evidence of wrongdoing. Committee assignments are current ones.

Transaction
Sold (full)
Amount
$50K–$100K
Owner
Spouse
Traded
Feb 10, 2025
Disclosed
Feb 21, 2025
Days to disclose
11
Asset type
Stock
As filed
Eli Lilly and Company Common Stock
Industry
Drug Manufacturers - General · Healthcare

Other trades in this filing

Recent Congress trades in LLY

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.